<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
      <Volume-Issue>Volume 10, Issue 4</Volume-Issue>
      <Season>October - December, 2018</Season>
      <ArticleTitle>Applications of quality risk management tool in pharmaceutical industry: A comprehensive review</ArticleTitle>
      <Abstract>The aim of this article is to provide better understanding in the application of the International Conference on Harmonization Q9 guideline. This paper reflects the need of quality risk management in pharmaceutical industry to improve and consistently working with quality. Quality risk management (QRM) can be applied at various stages in the industry consisting of manufacturing, distribution, inspection, and review of pharmaceutical products and any biological product throughout its lifecycle. QRM includes risk evaluation, risk control, and risk review. The risk evaluation provides regulator brief information about the severity of the risk and depending on severity of the risk appropriate risk management tool. The various risk management tools are described in this paper. Risk pertaining in the quality of product declining the firm’s growth so as to maintain the market response firm has to be consistent with the product quality. QRM shows how to implement, evaluate, control, and review the risk.</Abstract>
      <Keywords>Failure mode effect analysis, hazard management, international  conference on harmonization guidelines, quality risk management, risk management</Keywords>
        <Abstract>https://isfcppharmaspire.com/ubijournal-v1copy/journals/abstract.php?article_id=13876&amp;title=Applications of quality risk management tool in pharmaceutical industry: A comprehensive review</Abstract>
        <References>1. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Q9 Quality Risk Management. Geneva: ICH; 2005.&#13;
2. Vjayakumar R, Vishal G, Raghunandan V, Nitin KU. Quality risk management in pharmaceutical industry: A review. Int J Pharm Tech Res 2014;6:908-14.&#13;
3. International Conference on Harmonization Guidance for Industry: Q9 Quality Risk Management. ICH; 2006.&#13;
4. U.S Food and Drug Administration. Pharmaceutical CGMPS for the 21st Century-A Risk Based Approach. Rockville, MD: Food and Drug Administration; 2004.&#13;
5. Food and Drug Administration. Guidance for Industry: Quality Systems Approach to Pharmaceutical CGMP Regulations: Rockville, MD: Food and Drug Administration; 2006.&#13;
6. International Conference Harmonization. Pharmaceutical Quality System. ICH Harmonized Tripartite Guideline. Q10. Geneva, Switzerland: U.S. Department of Health and Human; 2008. &#13;
7. Lotlikar MV. Quality risk management (QRM): A review. J Drug Deliv Ther 2013;3:149-54.&#13;
8. ICH. Harmonized Tripartite Guideline. Development and Manufacture of Drug Substances (Chemic al Entities and Biotechnological/Biological Entities). Draft Consensus Guideline Q11; 2011.&#13;
9. ISO; 2000, Application of Risk Management to Medical Devices, ISO 14971; 2000. Available from: http://www.iso.org. [Last accessed on 2018 Dec]. &#13;
10. WHO Guideline on Quality Risk Management A Draft Guidance; 2010.</References>